Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Hepatology (Baltimore, Md.)
|
August 1, 2000
The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C
S C Gordon, J W Fang, A L Silverman, et al.
Journal of Virology
|
January 9, 1999
Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli
E Ferrari, J Wright-Minogue, J W Fang, et al.
Digestive Diseases and Sciences
|
September 1, 1994
Hepatic expression of interferon-alpha in chronic hepatitis B virus infection
J W Fang, P C Wu, C L Lai, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
May 27, 2026
[The application of breast cancer organoids in drug screening and gene function research]
Y Q Zhang, S H Wu, J W Fang, et al.
The American Journal of Pathology
|
October 1, 1996
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications
P C Wu, J W Fang, V K Lau, et al.
Liver
|
October 26, 1999
Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma
P C Wu, V K Lau, J W Fang, et al.
Journal of Viral Hepatitis
|
March 16, 2000
Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients
S B Slimane, J K Albrecht, J W Fang, et al.
Journal of Leukocyte Biology
|
April 28, 2011
Interleukin-17A differentially modulates BCG induction of cytokine production in human blood macrophages
J W Fang, James C B Li, K Y Au, et al.
Clinical Pharmacology and Therapeutics
|
December 5, 2000
Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group
P Glue, J W Fang, R Rouzier-Panis, et al.
Gastroenterology
|
September 1, 1993
Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant
J W Fang, F Y Tung, G L Davis, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Hepatology (Baltimore, Md.)
|
August 1, 2000
The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C
S C Gordon, J W Fang, A L Silverman, et al.
Journal of Virology
|
January 9, 1999
Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli
E Ferrari, J Wright-Minogue, J W Fang, et al.
Digestive Diseases and Sciences
|
September 1, 1994
Hepatic expression of interferon-alpha in chronic hepatitis B virus infection
J W Fang, P C Wu, C L Lai, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
May 27, 2026
[The application of breast cancer organoids in drug screening and gene function research]
Y Q Zhang, S H Wu, J W Fang, et al.
The American Journal of Pathology
|
October 1, 1996
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications
P C Wu, J W Fang, V K Lau, et al.
Liver
|
October 26, 1999
Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma
P C Wu, V K Lau, J W Fang, et al.
Journal of Viral Hepatitis
|
March 16, 2000
Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients
S B Slimane, J K Albrecht, J W Fang, et al.
Journal of Leukocyte Biology
|
April 28, 2011
Interleukin-17A differentially modulates BCG induction of cytokine production in human blood macrophages
J W Fang, James C B Li, K Y Au, et al.
Clinical Pharmacology and Therapeutics
|
December 5, 2000
Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group
P Glue, J W Fang, R Rouzier-Panis, et al.
Gastroenterology
|
September 1, 1993
Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant
J W Fang, F Y Tung, G L Davis, et al.
Page
of 3